NVS Novartis AG
Stock · NYSE · Switzerland · Healthcare · US66987V1098
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Novartis AG, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
162.55 USD
+0.38%
52-week range
123.24 – 170.46
Dividend yield2.92%
Market cap307.0B
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:45. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 11 May 2026 – 15 May 2026 | 146.59 | 150.56 | 144.75 | 148.08 | +1.40% | 6,643,300 | |
| 04 May 2026 – 08 May 2026 | 145.55 | 148.76 | 144.45 | 146.03 | -0.37% | 6,237,100 | |
| 27 Apr 2026 – 01 May 2026 | 144.67 | 148.58 | 142.25 | 146.57 | +0.76% | 8,364,200 | |
| 20 Apr 2026 – 24 Apr 2026 | 151.40 | 152.04 | 144.05 | 145.47 | -4.28% | 7,359,900 | |
| 13 Apr 2026 – 17 Apr 2026 | 153.72 | 155.05 | 149.38 | 151.97 | -1.35% | 5,332,000 | |
| 06 Apr 2026 – 10 Apr 2026 | 153.59 | 156.46 | 149.49 | 154.05 | +0.01% | 7,230,500 | |
| 30 Mar 2026 – 02 Apr 2026 | 150.25 | 156.08 | 149.56 | 154.03 | +3.95% | 8,339,100 | |
| 23 Mar 2026 – 27 Mar 2026 | 147.21 | 151.78 | 146.22 | 148.18 | +1.47% | 7,202,800 | |
| 16 Mar 2026 – 20 Mar 2026 | 154.54 | 155.79 | 145.30 | 146.03 | -4.83% | 10,728,300 | |
| 09 Mar 2026 – 13 Mar 2026 | 159.52 | 163.08 | 153.18 | 153.44 | -4.17% | 14,550,900 | 4.7730 |
| 02 Mar 2026 – 06 Mar 2026 | 167.16 | 167.61 | 156.18 | 160.12 | -5.04% | 16,257,700 | |
| 23 Feb 2026 – 27 Feb 2026 | 163.66 | 170.46 | 163.66 | 168.62 | +3.66% | 16,438,800 | |
| 17 Feb 2026 – 20 Feb 2026 | 166.78 | 167.86 | 161.75 | 162.67 | -0.26% | 8,784,500 | |
| 09 Feb 2026 – 13 Feb 2026 | 156.98 | 163.42 | 155.94 | 163.10 | +4.27% | 13,457,300 | |
| 02 Feb 2026 – 06 Feb 2026 | 149.63 | 156.62 | 149.38 | 156.42 | +5.21% | 16,857,300 | |
| 26 Jan 2026 – 30 Jan 2026 | 148.29 | 152.48 | 146.84 | 148.68 | +1.05% | 9,838,800 | |
| 20 Jan 2026 – 23 Jan 2026 | 144.00 | 148.10 | 142.82 | 147.14 | +1.94% | 6,818,900 | |
| 12 Jan 2026 – 16 Jan 2026 | 142.98 | 146.35 | 140.31 | 144.34 | +1.98% | 8,141,800 | |
| 05 Jan 2026 – 09 Jan 2026 | 137.14 | 143.49 | 135.55 | 141.54 | +2.17% | 9,199,700 | |
| 29 Dec 2025 – 02 Jan 2026 | 138.86 | 139.45 | 137.02 | 138.54 | -0.46% | 3,283,900 | |
| 22 Dec 2025 – 26 Dec 2025 | 136.48 | 140.18 | 136.00 | 139.18 | +2.29% | 4,568,200 | |
| 15 Dec 2025 – 19 Dec 2025 | 133.90 | 137.40 | 133.67 | 136.06 | +2.63% | 8,752,400 | |
| 08 Dec 2025 – 12 Dec 2025 | 132.83 | 133.84 | 129.98 | 132.57 | +0.31% | 9,730,100 | |
| 01 Dec 2025 – 05 Dec 2025 | 131.02 | 134.24 | 128.91 | 132.16 | +1.35% | 8,070,000 | |
| 24 Nov 2025 – 28 Nov 2025 | 127.44 | 131.19 | 126.50 | 130.40 | +2.43% | 6,556,300 |
Page 2 of 11
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Novartis shelves potential blockbuster pelacarsen as landmark study fails (opens in a new tab) Investing.com · 07 Nov 2026 15:46
- Update: Market Chatter: Novartis Reports Two Confirmed Tumor Cases Linked to Neuromuscular Gene Therapy (opens in a new tab) MT Newswires · 06 Nov 2026 10:48
- $1000 Invested In Novartis 5 Years Ago Would Be Worth This Much Today (opens in a new tab) Benzinga · 05 Nov 2026 19:15
- Novartis: 3 Key Takeaways for Long-Term Investors (opens in a new tab) Motley Fool · 04 Nov 2026 01:47
- BioArctic collaborator Novartis terminates agreement (opens in a new tab) 02 Nov 2026 21:36
- BioArctic AB Announces Novartis Terminates Their 2025 Option, Collaboration And License Deal; BioArctic To Retain Full $30M Upfront Payment (opens in a new tab) Benzinga · 02 Nov 2026 17:49
- Deutsche Bank turns bearish on Novartis as shares recover failed trial losses (opens in a new tab) Investing.com · 02 Nov 2026 10:16
- Allarity Therapeutics Settles $4.9M Novartis Liability For $1M Payment (opens in a new tab) Benzinga · 02 Nov 2026 09:06
- Novartis (SWX:NOVN) Reports Longer Survival In Advanced Kidney Cancer Trial (opens in a new tab) Simply Wall St. · 02 Nov 2026 01:07
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 161.93 USD
- Market cap
- 307.0B
- Dividend yield
- 2.92%
- 5-year average yield
- 3.46%
- Payout ratio
- 90%
- Last dividend
- 4.7730 USD · 11 Mar 2026
- Exchange
- NYSE
- Country
- Switzerland
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 11 Mar 2026 | 4.7730 USD |
| 12 Mar 2025 | 3.9940 USD |
| 07 Mar 2024 | 3.7400 USD |
| 09 Mar 2023 | 3.4690 USD |
| 08 Mar 2022 | 3.3570 USD |
| 04 Mar 2021 | 3.3780 USD |
| 03 Mar 2020 | 3.0420 USD |
| 04 Mar 2019 | 2.5672 USD |
| 06 Mar 2018 | 2.6676 USD |
| 01 Mar 2017 | 2.4606 USD |
| 24 Feb 2016 | 2.4749 USD |
| 02 Mar 2015 | 2.5242 USD |
Follow NVS and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.